序号 |
标题 |
次数 |
作者 |
发布时间 |
68536 |
SLinPS,cas:322647-11-0,1-硬脂酰-2-亚油酰磷脂酰丝氨酸(钠盐) |
82 |
axc |
2025-01-02 |
68537 |
cas:1353897-91-2,1-棕榈酰基-2-炔丙基乙酰磷脂酰胆碱,1-palmitoyl-2-(propargylacetyl)-sn-glycero-3-phosphocholine |
89 |
axc |
2025-01-02 |
68538 |
DPhPC,cas:207131-40-6,二植酰磷脂酰胆碱 |
86 |
axc |
2025-01-02 |
68539 |
DSPE-MPEG2000,cas:147867-65-0,二硬脂酰磷脂酰乙醇胺-聚乙二醇2000 |
163 |
axc |
2025-01-02 |
68540 |
DPPE,cas:923-61-5,磷脂酰乙醇胺,1,2-Dipalmitoyl-sn-glycero-3-phosphoethanolamine |
167 |
axc |
2025-01-02 |
68541 |
P-LysoPC,cas:17364-16-8,1-十六酰-sn-丙三醇-磷酸胆碱 |
114 |
axc |
2025-01-02 |
68542 |
DLPC,cas:18194-25-7,1,2-二月桂酰基-sn-glycero-3-胆碱磷酸 |
81 |
axc |
2025-01-02 |
68543 |
HSPC/Chol/DSPE-mPEG2000/MPL (56.2/38.5/4.3/1, mol/mol) Liposomes,HSPC/Chol/DSPE-mPEG2000/MPL脂质体 |
93 |
axc |
2024-12-31 |
68544 |
DOTAP/DOPE (50/50, mol/mol) Liposomes,DOTAP/DOPE (50/50,摩尔/摩尔)脂质体 |
117 |
axc |
2024-12-31 |
68545 |
Adavosertib Liposomes, Formulation WD4,阿达沃塞替布脂质体,制剂WD4 |
280 |
axc |
2024-12-31 |
68546 |
Mirdametinib (PD0325901) Liposomes, Formulation U6-2,Mirdametinib (PD0325901)脂质体,配方U6-2 |
156 |
axc |
2024-12-31 |
68547 |
DT-061 (SMAP) Liposomes, Formulation TT-40,DT-061 (SMAP)脂质体,制剂TT-40 |
106 |
axc |
2024-12-31 |
68548 |
Tanespimycin (17-AAG) Liposomes, Formulation XT28.1,坦那霉素(17-AAG)脂质体,配方XT28.1 |
102 |
axc |
2024-12-31 |
68549 |
Nexturastat A Liposomes,Nexturastat A脂质体,靶向脂质体定制服务 |
97 |
axc |
2024-12-31 |
68550 |
A939572 Liposomes,A939572脂质体,靶向脂质体定制服务 |
125 |
axc |
2024-12-31 |
68551 |
Eganelisib (IPI-549) Liposomes, Formulation WNX5.2,Eganelisib (IPI-549)脂质体,制剂WNX5.2 |
173 |
axc |
2024-12-31 |
68552 |
Lificiguat (YC-1) Liposomes, Formulation FNT8P.2,Lificiguat (YC-1)脂质体,制剂FNT8P.2 |
90 |
axc |
2024-12-31 |
68553 |
SP600125 Liposomes, Formulation HZ12,SP600125脂质体,配方HZ12 |
105 |
axc |
2024-12-31 |
68554 |
Rocaglamide Liposomes, Formulation KHE9A,罗卡酰胺脂质体,配方KHE9A |
100 |
axc |
2024-12-31 |
68555 |
Gilteritinib (ASP2215) Liposomes,吉尔替尼(ASP2215)脂质体 |
98 |
axc |
2024-12-31 |
68556 |
CAS:125503-35-7 双(2,5-二氧吡咯烷-1-基)2,2'-(丙烷-2,2-二基双(磺胺基)二乙酸酯) |
116 |
zhn |
2024-12-31 |
68557 |
AZD1208 Liposomes, Formulation RB4T4,AZD1208脂质体,配方RB4T4 |
72 |
axc |
2024-12-31 |
68558 |
DiR Labeled Tumor-Accumulating Liposomes邃,DiR标记的肿瘤积聚脂质体 |
104 |
axc |
2024-12-31 |
68559 |
氧化锌量子点(ZnO QDs) 无机半导体材料 |
194 |
zhn |
2024-12-31 |
68560 |
聚多巴胺微球 |
177 |
zhn |
2024-12-31 |
68561 |
PS-R-PMMA 聚苯乙烯(PS)和聚甲基丙烯酸甲酯(PMMA)共聚物 |
306 |
zhn |
2024-12-31 |
68562 |
AgBiS₂量子点 银铋硫化物量子点 |
124 |
zhn |
2024-12-31 |
68563 |
单层石墨相氮化碳纳米片(Graphitic Carbon Nitride, g-C₃N₄) |
257 |
zhn |
2024-12-31 |
68564 |
HSPC/胆固醇/DSPE-mPEG2000 (56.2/38.5/5.3,摩尔/摩尔)脂质体(DiD标记),脂质体定制服务 |
124 |
axc |
2024-12-31 |
68565 |
HSPC/Chol/DSPE-mPEG2000 (56.2/38.5/5.3, mol/mol) Liposomes (DiD-labeled),脂质体定制服务 |
136 |
axc |
2024-12-31 |
68566 |
环糊精修饰螺吡类分子 |
85 |
zhn |
2024-12-31 |
68567 |
HSPC/胆固醇/DSPE-聚乙二醇2000/DSPE-聚乙二醇2000-马来酰亚胺(50/45/4/1,摩尔/摩尔)脂质体,脂质体定制服务 |
123 |
axc |
2024-12-31 |
68568 |
二氧化硅包纳米金棒 SiO₂@Au nanorods |
106 |
zhn |
2024-12-31 |
68569 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide (50/45/4/1, mol/mol) Liposomes,脂质体定制服务 |
128 |
axc |
2024-12-31 |
68570 |
四氧化三铁二硫化钼复合材料 Fe₃O₄@MoS₂ |
234 |
zhn |
2024-12-31 |
68571 |
17-(Azide-PEG9-ethylcarbamoyl)heptadecanoic t-butyl ester |
84 |
h |
2024-12-31 |
68572 |
14-(Azide-PEG6-ethylcarbamoyl)tridecanoic-t-butyl ester |
75 |
h |
2024-12-31 |
68573 |
IR-700-NH2 氨基化的近红外荧光染料 |
176 |
zhn |
2024-12-31 |
68574 |
HSPC/Chol/DSPE-mpeg 2000/DSPE-mpeg 2000-马来酰亚胺/MPL (49/45/4/1/1,摩尔/摩尔)脂质体,脂质体定制服务 |
89 |
axc |
2024-12-31 |
68575 |
14-(Azide-PEG4-ethylcarbamoyl)tridecanoic-t-butyl ester |
88 |
h |
2024-12-31 |
68576 |
Amine-PEG5-c18-t-butyl ester |
142 |
h |
2024-12-31 |
68577 |
HSPC/Chol/DSPE-mPEG2000/DSPE-mPEG2000-maleimide/MPL(49/45/4/1/1, mol/mol) Liposomes,脂质体定制服务 |
148 |
axc |
2024-12-31 |
68578 |
PS22500-EHA100000-PS22500 一种嵌段共聚物 |
89 |
zhn |
2024-12-31 |
68579 |
16-(Amine-PEG3-ethylcarbamoyl)pentadecanoic-t-butyl ester |
118 |
h |
2024-12-31 |
68580 |
PCN-224 金属有机骨架 |
577 |
zhn |
2024-12-31 |